{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Saxagliptin%2C+Onglyza&page=3", "query": { "intervention": "Saxagliptin, Onglyza", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 61, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Saxagliptin%2C+Onglyza&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Saxagliptin%2C+Onglyza&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-12T03:10:31.936Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00757588", "title": "Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Saxagliptin, 5 mg + insulin", "type": "DRUG" }, { "name": "Placebo + insulin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "78 Years", "sex": "ALL", "summary": "18 Years to 78 Years" }, "enrollment_count": 455, "start_date": "2008-11", "completion_date": "2010-04", "has_results": true, "last_update_posted_date": "2015-06-01", "last_synced_at": "2026-10-12T03:10:31.936Z", "location_count": 16, "location_summary": "Tempe, Arizona • Fresno, California • Lomita, California + 13 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Lomita", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00757588" }, { "nct_id": "NCT03169959", "title": "A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "2.5 mg Saxagliptin tablet", "type": "DRUG" }, { "name": "5 mg dapagliflozin / 1000 mg metformin XR tablet", "type": "DRUG" }, { "name": "Triple FCDP - 2.5 mg saxagliptin / 5 mg dapagliflozin / 1000 mg metformin XR", "type": "DRUG" }, { "name": "5 mg saxagliptin", "type": "DRUG" }, { "name": "10 mg dapagliflozin / 1000 mg metformin XR tablet", "type": "DRUG" }, { "name": "Triple FCDP - 5 mg saxagliptin / 10 mg dapagliflozin / 1000 mg metformin XR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 85, "start_date": "2017-05-29", "completion_date": "2017-08-03", "has_results": false, "last_update_posted_date": "2017-08-14", "last_synced_at": "2026-10-12T03:10:31.936Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03169959" }, { "nct_id": "NCT01606007", "title": "Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Saxagliptin", "type": "DRUG" }, { "name": "Metformin XR", "type": "DRUG" }, { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Placebo matching with Dapagliflozin", "type": "DRUG" }, { "name": "Placebo matching with Saxagliptin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1282, "start_date": "2012-07", "completion_date": "2014-01", "has_results": true, "last_update_posted_date": "2017-05-15", "last_synced_at": "2026-10-12T03:10:31.936Z", "location_count": 80, "location_summary": "Birmingham, Alabama • Homewood, Alabama • Muscle Shoals, Alabama + 73 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Ozark", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01606007" }, { "nct_id": "NCT00885378", "title": "Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Saxagliptin plus metformin IR", "type": "DRUG" }, { "name": "Placebo plus metformin IR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "78 Years", "sex": "ALL", "summary": "18 Years to 78 Years" }, "enrollment_count": 166, "start_date": "2009-05", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2015-06-01", "last_synced_at": "2026-10-12T03:10:31.936Z", "location_count": 25, "location_summary": "Concord, California • Fountain Valley, California • Lomita, California + 22 more", "locations": [ { "city": "Concord", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Lomita", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Altamonte Springs", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00885378" }, { "nct_id": "NCT00374907", "title": "A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Saxagliptin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Metformin (blinded)", "type": "DRUG" }, { "name": "Metformin (open-label)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 156, "start_date": "2006-09", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2015-05-07", "last_synced_at": "2026-10-12T03:10:31.936Z", "location_count": 3, "location_summary": "San Diego, California • Baton Rouge, Louisiana • San Antonio, Texas", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00374907" }, { "nct_id": "NCT00918138", "title": "Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Saxagliptin", "type": "DRUG" }, { "name": "Metformin XR", "type": "DRUG" }, { "name": "Placebo matching Metformin XR", "type": "DRUG" }, { "name": "Placebo matching Saxagliptin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "78 Years", "sex": "ALL", "summary": "18 Years to 78 Years" }, "enrollment_count": 219, "start_date": "2009-08", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2015-05-21", "last_synced_at": "2026-10-12T03:10:31.936Z", "location_count": 12, "location_summary": "Phoenix, Arizona • Redlands, California • Tustin, California + 9 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Redlands", "state": "California" }, { "city": "Tustin", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00918138" }, { "nct_id": "NCT00121667", "title": "Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Saxagliptin + Metformin", "type": "DRUG" }, { "name": "Placebo + Metformin", "type": "DRUG" }, { "name": "Pioglitazone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "77 Years", "sex": "ALL", "summary": "18 Years to 77 Years" }, "enrollment_count": 1462, "start_date": "2005-08", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2015-04-29", "last_synced_at": "2026-10-12T03:10:31.936Z", "location_count": 95, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Calera, Alabama + 92 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Calera", "state": "Alabama" }, { "city": "Haleyville", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00121667" }, { "nct_id": "NCT00614939", "title": "Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Saxagliptin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 572, "start_date": "2008-01", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2011-05-19", "last_synced_at": "2026-10-12T03:10:31.936Z", "location_count": 11, "location_summary": "Concord, California • Sacramento, California • Denver, Colorado + 8 more", "locations": [ { "city": "Concord", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Topeka", "state": "Kansas" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00614939" }, { "nct_id": "NCT01068717", "title": "Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Saxagliptin, 2.5 mg + Metformin, 500 mg (fasted state)", "type": "DRUG" }, { "name": "Saxagliptin, 2.5 mg /Metformin, 500 mg FDC (fasted state)", "type": "DRUG" }, { "name": "Saxagliptin, 2.5 mg + Metformin, 500 mg (fed state)", "type": "DRUG" }, { "name": "Saxagliptin, 2.5 mg /Metformin, 500 mg FDC (fed state)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 27, "start_date": "2010-03", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2015-05-12", "last_synced_at": "2026-10-12T03:10:31.936Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01068717" }, { "nct_id": "NCT00899470", "title": "Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Co-administration of Saxagliptin and Metformin IR, Fasted", "type": "DRUG" }, { "name": "Saxagliptin/Metformin, Fasting", "type": "DRUG" }, { "name": "Co-administration of Saxagliptin and Metformin IR, Fed", "type": "DRUG" }, { "name": "Saxagliptin/Metformin, Fed", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "19 Years to 45 Years" }, "enrollment_count": 24, "start_date": "2009-06", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2015-06-01", "last_synced_at": "2026-10-12T03:10:31.936Z", "location_count": 1, "location_summary": "Lincoln, Nebraska", "locations": [ { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT00899470" } ] }